cyclooxygenase-2/5-lipoxygenase dual inhibitors (Medisyn Technologies)

N/A

Report date: 2025/03/19 20:00:56
NME

Base Information

Drug Namecyclooxygenase-2/5-lipoxygenase dual inhibitors (Medisyn Technologies)
Drug Alias Namenon-steroidal anti-inflammatory agents (Medisyn Technologies)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclooxygenase-2 inhibitorsArachidonate 5-lipoxygenase inhibitors
TargetsCyclooxygenase-2Arachidonate 5-lipoxygenase
Therapy Area/IndicationsInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMedisyn Technologies Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMedisyn Technologies Inc
Active IndicationsN/A
Inactive IndicationsInflammation

Other Information

ATC CodeN/A
Related LinksN/A